FBR Capital Starts Arch Coal (ARCH) at Outperform

October 5, 2016 7:09 AM EDT
Get Alerts ARCH Hot Sheet
Price: $79.32 +2.06%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade ARCH Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

FBR Capital initiates coverage on Arch Coal (NYSE: ARCH) (not trading, emerging from bk) with an Outperform rating and a price target of $71.00.

Analyst Lucas Pipes commented, "We are initiating coverage on Arch Coal with an Outperform rating and a price target of $71 per share. Arch Coal's new equity is emerging from a balance sheet restructuring that has left its low-cost operating assets unchanged: high-quality met coal production in the East and PRB thermal coal exposure in the West. In the course of the restructuring, the company right sized its balance sheet, eliminated uneconomical off-take agreements, and lowered production costs even further. While we always considered Arch a strong operator, we believe the company is now positioned to prosper in almost any coal price environment. Near term, we see the company's met coal exposure as its greatest catalyst. With 7.0 MT to 7.5 MT of met coal sales anticipated in 2017, Arch Coal, we believe, is now among the largest domestic met coal producers, ready to take advantage of the higher price environment. We do believe that the domestic thermal coal market is also turning the corner from a very challenging 1H16, potentially leading to higher sales and prices in Arch's large PRB platform. We would take advantage of Arch's unique position and accumulate aggressively into the $60s per share."

For an analyst ratings summary and ratings history on Arch Coal click here. For more ratings news on Arch Coal click here.

Shares of Arch Coal closed at $ yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, New Coverage

Add Your Comment